A detailed history of Ever Source Wealth Advisors, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 574 shares of INVA stock, worth $9,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
574
Previous 574 -0.0%
Holding current value
$9,918
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

SELL
$12.37 - $13.89 $1,274 - $1,430
-103 Reduced 15.21%
574 $7,000
Q2 2023

Aug 04, 2023

SELL
$11.39 - $13.72 $10,216 - $12,306
-897 Reduced 56.99%
677 $8,000
Q1 2023

May 11, 2023

BUY
$10.73 - $13.6 $15,676 - $19,869
1,461 Added 1292.92%
1,574 $17,000
Q4 2021

Feb 07, 2022

BUY
$15.91 - $18.72 $1,797 - $2,115
113 New
113 $2,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.2B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.